Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

BlackRock Health Sciences Trust

Financial Services US BME

39.93USD
0.06(0.15%)

Last update at 2026-06-05T20:00:00Z

Day Range

39.9340.65
LowHigh

52 Week Range

32.4342.18
LowHigh

Fundamentals

  • Previous Close 39.87
  • Market Cap507.27M
  • Volume43174
  • P/E Ratio6.63
  • Dividend Yield7.93%
  • Revenue TTM7.74M
  • Revenue Per Share TTM0.60
  • Gross Profit TTM 7.74M
  • Diluted EPS TTM5.92

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-10-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-10-31
Income before tax 76.97M 23.45M 20.02M -26.47108M -26.47108M
Minority interest - - - - -
Net income 76.97M 23.45M 20.02M -26.47108M -26.47108M
Selling general administrative 0.44M 0.36M 6.19M 0.36M 0.36M
Selling and marketing expenses - - 5.89M - -
Gross profit 30.53M 24.07M 2.17M -25.97095M -25.97095M
Reconciled depreciation - - - - -
Ebit - 24.43M 22.03M -26.47108M 1.54M
Ebitda 77.01M 23.50M 20.02M -26.47108M -26.47108M
Depreciation and amortization - -0.92718M -2.00558M -1.53956M -
Non operating income net other - - - - -
Operating income 77.00M 23.45M 2.01M -26.47108M -26.47108M
Other operating expenses 40.84M 0.62M 6.19M 0.50M 0.50M
Interest expense 0.05M 0.00008M 0.00006M - -
Tax provision - - - - -
Interest income 0.00000M 0.00000M 0.00000M - -
Net interest income -0.00009M -0.00008M -0.00006M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 2.01M 1.53M -
Total revenue 36.16M 24.07M 8.19M -25.97095M -25.97095M
Total operating expenses -46.46406M 0.62M 6.19M 0.50M 0.50M
Cost of revenue 5.63M 0.00008M 6.02M 5.94M -
Total other income expense net -0.02770M 70.36M 18.01M -0.01232M -
Discontinued operations - - - - -
Net income from continuing ops 76.97M 23.45M 20.02M -26.47108M -26.47108M
Net income applicable to common shares - - - -26.47108M -26.47108M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-10-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-10-31
Total assets 570.14M 774.59M 596.10M 606.13M 606.13M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - -1.19548M 0.04M -26.24293M -
Total liab 1.83M 6.03M 7.97M 5.93M 5.93M
Total stockholder equity 568.30M 768.57M 588.14M 600.20M 600.20M
Deferred long term liab - - - 0.08M 0.08M
Other current liab -0.21196M -1.09097M -0.06069M -0.23612M -0.23320M
Common stock 357.61M 942.10M 417.62M 424.30M 424.30M
Capital stock 357.61M 942.10M 417.62M 424.30M 424.30M
Retained earnings 210.69M -173.53028M 170.52M 175.90M 175.90M
Other liab - - - - -
Good will - - - - -
Other assets - -25.29198M -4.87310M 0.08M 0.08M
Cash 0.00055M 0.07M 0.00053M 0.00312M -
Cash and equivalents - - - - -
Total current liabilities - - 7.96M 0.23M 0.23M
Current deferred revenue - - - 0.23M -
Net debt 0.89M -0.07134M 0.06M -0.00020M 0.00292M
Short term debt - 0.02M 0.06M 0.00292M -
Short long term debt - - - - -
Short long term debt total 0.89M 0.30M 0.06M 0.00292M 0.00292M
Other stockholder equity - - -170.51763M -175.89685M -
Property plant equipment - - - - -
Total current assets 5.34M 26.56M 1.62M 2.37M 2.37M
Long term investments 569.69M 773.33M 594.40M 603.68M 603.68M
Net tangible assets - - - 600.20M 600.20M
Short term investments 4.92M 26.49M 31.40M 23.87M -
Net receivables 0.43M 1.20M 1.58M 2.37M 2.37M
Long term debt - - - - -
Inventory - - - 0.00000M -
Accounts payable 0.21M 0.49M - 0.23M 0.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 210.69M - 0.00000M 175.90M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.02M -223.36295M -594.40047M -603.68294M -603.68294M
Deferred long term asset charges - - - - -
Non current assets total 564.79M 549.96M 599.36M 603.68M 603.68M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-10-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2022-10-31
Investments - - - - -
Change to liabilities - - - 0.00000M 0.00000M
Total cashflows from investing activities 37.30M - - - -
Net borrowings 0.00000M -0.06069M - 0.00292M 0.00292M
Total cash from financing activities -54.58828M -65.51564M -32.02123M 0.88M 0.88M
Change to operating activities - - - 0.50M 0.50M
Net income 76.97M 23.45M 20.02M -26.47108M -26.47108M
Change in cash -0.00550M 0.00551M -0.00258M 0.00216M 0.00216M
Begin period cash flow 0.00605M 0.00053M 0.00312M 0.00096M 0.00096M
End period cash flow 0.00055M 0.00605M 0.00053M 0.00312M 0.00312M
Total cash from operating activities -4.35116M 65.52M 32.02M -0.87404M -0.87404M
Issuance of capital stock - - 3.02M 33.62M 33.62M
Depreciation - - - - -
Other cashflows from investing activities - -66.41252M - - -
Dividends paid 40.61M 35.92M 35.10M 32.73M 32.73M
Change to inventory - - - - -
Change to account receivables -0.02543M 0.22M -0.01782M -0.15955M -0.15955M
Sale purchase of stock -13.97764M -29.53271M 0.12M -0.00292M 0.00000M
Other cashflows from financing activities - - -0.00099M -0.01701M -0.01701M
Change to netincome - - - 25.27M 25.27M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.74M 0.51M -0.76540M 0.33M 0.33M
Stock based compensation - - - - -
Other non cash items -82.06011M 41.56M 12.77M 25.27M 25.27M
Free cash flow -4.35116M 65.52M 32.02M -0.87404M -0.87404M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
BME
BlackRock Health Sciences Trust		 0.06 0.15% 39.93 6.63 - 65.57 0.89 6.54
BLK
BlackRock Inc		 -26.96 2.64% 995.60 26.25 19.57 6.33 2.90 6.35 17.13
BX
Blackstone Group Inc		 -3.2 2.70% 115.35 33.20 20.12 11.05 11.56 9.14 15.74
BN
Brookfield Corp		 -0.45 1.00% 44.60 94.78 11.89 1.35 2.37 4.58 10.79
IVSXF
Investor AB (publ)		 - -% 40.41 20.83 - 0.88 1.11 10.01 1.68

Reports Covered

Stock Research & News

View All

Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BlackRock Health Sciences Trust

50 Hudson Yards, New York, NY, United States, 10001

Key Executives

Name Title Year Born
Mr. Charles Choon Sik Park Chief Compliance Officer and Anti-Money Laundering Officer 1967
Mr. Thomas P. Callan C.F.A. Portfolio Mang. NA
Mr. Kyle G. McClements C.F.A., CFA Portfolio Mang. NA
Dr. Erin Xie Ph.D. Portfolio Mang. 1968
Mr. Christopher M. Accettella Portfolio Mang. NA
Mr. Jeffrey Gene Lee Portfolio Mang. NA
Dr. Xiang Liu Ph.D. Portfolio Mang. NA
Mr. Thomas P. Callan C.F.A. Portfolio Manager NA
Mr. Kyle G. McClements C.F.A. Portfolio Manager NA
Dr. Erin Xie Ph.D. Portfolio Manager 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.